PPARG and Alzheimer disease: However, after treatment of the activators of PPARγ/AMPK signaling pathway, the expression level of IDE was increased significantly, the accumulation of Aβ40 and Aβ42 was decreased, and the activators also alleviated the spatial learning and recognition impairments in mice with T2D and AD.